Takeda Pharmaceutical Receivables 2010-2024 | TAK

Takeda Pharmaceutical receivables for the quarter ending September 30, 2024 were $4.943B, a 17.97% decline year-over-year.

  • Takeda Pharmaceutical receivables for 2024 were $4.814B, a 4.58% decline from 2023.
  • Takeda Pharmaceutical receivables for 2023 were $5.045B, a 21.75% decline from 2022.
  • Takeda Pharmaceutical receivables for 2022 were $6.447B, a 15.61% decline from 2021.

Takeda Pharmaceutical Receivables 2010-2024 | TAK

  • Takeda Pharmaceutical receivables for 2024 were $4.814B, a 4.58% decline from 2023.
  • Takeda Pharmaceutical receivables for 2023 were $5.045B, a 21.75% decline from 2022.
  • Takeda Pharmaceutical receivables for 2022 were $6.447B, a 15.61% decline from 2021.